Cargando…

The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population

The controlled attenuation parameter (CAP) measurement obtained from FibroScan(®) is a low-risk method of assessing fatty liver. This study investigated the association between the FibroScan(®) CAP values and nine anthropometric indicators, including the abdominal volume index (AVI), body fat percen...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Meng-Szu, Felipe-Dimog, Eva Belingon, Yang, Jeng-Fu, Chen, Yi-Yu, Wu, Kuan-Ta, Kuo, Hsiang-Ju, Lin, Tzu-Chun, Wang, Chao-Ling, Hsieh, Meng-Hsuan, Lin, Chia-Yi, Batsaikhan, Batbold, Ho, Chi-Kung, Wu, Ming-Tsang, Dai, Chia-Yen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526368/
https://www.ncbi.nlm.nih.gov/pubmed/37760959
http://dx.doi.org/10.3390/biomedicines11092518
_version_ 1785111005307600896
author Lee, Meng-Szu
Felipe-Dimog, Eva Belingon
Yang, Jeng-Fu
Chen, Yi-Yu
Wu, Kuan-Ta
Kuo, Hsiang-Ju
Lin, Tzu-Chun
Wang, Chao-Ling
Hsieh, Meng-Hsuan
Lin, Chia-Yi
Batsaikhan, Batbold
Ho, Chi-Kung
Wu, Ming-Tsang
Dai, Chia-Yen
author_facet Lee, Meng-Szu
Felipe-Dimog, Eva Belingon
Yang, Jeng-Fu
Chen, Yi-Yu
Wu, Kuan-Ta
Kuo, Hsiang-Ju
Lin, Tzu-Chun
Wang, Chao-Ling
Hsieh, Meng-Hsuan
Lin, Chia-Yi
Batsaikhan, Batbold
Ho, Chi-Kung
Wu, Ming-Tsang
Dai, Chia-Yen
author_sort Lee, Meng-Szu
collection PubMed
description The controlled attenuation parameter (CAP) measurement obtained from FibroScan(®) is a low-risk method of assessing fatty liver. This study investigated the association between the FibroScan(®) CAP values and nine anthropometric indicators, including the abdominal volume index (AVI), body fat percentage (BFP), body mass index (BMI), conicity index (CI), ponderal index (PI), relative fat mass (RFM), waist circumference (WC), waist–hip ratio (WHR), and waist-to-height ratio (WHtR), and risk of non-alcoholic fatty liver disease (fatty liver). We analyzed the medical records of adult patients who had FibroScan(®) CAP results. CAP values <238 dB/m were coded as 0 (non- fatty liver) and ≥238 dB/m as 1 (fatty liver). An individual is considered to have class 1 obesity when their body mass index (BMI) ranges from 30 kg/m(2) to 34.9 kg/m(2). Class 2 obesity is defined by a BMI ranging from 35 kg/m(2) to 39.9 kg/m(2), while class 3 obesity is designated by a BMI of 40 kg/m(2) or higher. Out of 1763 subjects, 908 (51.5%) had fatty liver. The BMI, WHtR, and PI were found to be more strongly correlated with the CAP by the cluster dendrogram with correlation coefficients of 0.58, 0.54, and 0.54, respectively (all p < 0.0001). We found that 28.3% of the individuals without obesity had fatty liver, and 28.2% of the individuals with obesity did not have fatty liver. The BMI, CI, and PI were significant predictors of fatty liver. The BMI, PI, and WHtR demonstrated better predictive ability, indicated by AUC values of 0.72, 0.68, and 0.68, respectively, a finding that was echoed in our cluster group analysis that showed interconnected clustering with the CAP. Therefore, of the nine anthropometric indicators we studied, the BMI, CI, PI, and WHtR were found to be more effective in predicting the CAP score, i.e., fatty liver.
format Online
Article
Text
id pubmed-10526368
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-105263682023-09-28 The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population Lee, Meng-Szu Felipe-Dimog, Eva Belingon Yang, Jeng-Fu Chen, Yi-Yu Wu, Kuan-Ta Kuo, Hsiang-Ju Lin, Tzu-Chun Wang, Chao-Ling Hsieh, Meng-Hsuan Lin, Chia-Yi Batsaikhan, Batbold Ho, Chi-Kung Wu, Ming-Tsang Dai, Chia-Yen Biomedicines Article The controlled attenuation parameter (CAP) measurement obtained from FibroScan(®) is a low-risk method of assessing fatty liver. This study investigated the association between the FibroScan(®) CAP values and nine anthropometric indicators, including the abdominal volume index (AVI), body fat percentage (BFP), body mass index (BMI), conicity index (CI), ponderal index (PI), relative fat mass (RFM), waist circumference (WC), waist–hip ratio (WHR), and waist-to-height ratio (WHtR), and risk of non-alcoholic fatty liver disease (fatty liver). We analyzed the medical records of adult patients who had FibroScan(®) CAP results. CAP values <238 dB/m were coded as 0 (non- fatty liver) and ≥238 dB/m as 1 (fatty liver). An individual is considered to have class 1 obesity when their body mass index (BMI) ranges from 30 kg/m(2) to 34.9 kg/m(2). Class 2 obesity is defined by a BMI ranging from 35 kg/m(2) to 39.9 kg/m(2), while class 3 obesity is designated by a BMI of 40 kg/m(2) or higher. Out of 1763 subjects, 908 (51.5%) had fatty liver. The BMI, WHtR, and PI were found to be more strongly correlated with the CAP by the cluster dendrogram with correlation coefficients of 0.58, 0.54, and 0.54, respectively (all p < 0.0001). We found that 28.3% of the individuals without obesity had fatty liver, and 28.2% of the individuals with obesity did not have fatty liver. The BMI, CI, and PI were significant predictors of fatty liver. The BMI, PI, and WHtR demonstrated better predictive ability, indicated by AUC values of 0.72, 0.68, and 0.68, respectively, a finding that was echoed in our cluster group analysis that showed interconnected clustering with the CAP. Therefore, of the nine anthropometric indicators we studied, the BMI, CI, PI, and WHtR were found to be more effective in predicting the CAP score, i.e., fatty liver. MDPI 2023-09-12 /pmc/articles/PMC10526368/ /pubmed/37760959 http://dx.doi.org/10.3390/biomedicines11092518 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lee, Meng-Szu
Felipe-Dimog, Eva Belingon
Yang, Jeng-Fu
Chen, Yi-Yu
Wu, Kuan-Ta
Kuo, Hsiang-Ju
Lin, Tzu-Chun
Wang, Chao-Ling
Hsieh, Meng-Hsuan
Lin, Chia-Yi
Batsaikhan, Batbold
Ho, Chi-Kung
Wu, Ming-Tsang
Dai, Chia-Yen
The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population
title The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population
title_full The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population
title_fullStr The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population
title_full_unstemmed The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population
title_short The Efficacy of Anthropometric Indicators in Predicting Non-Alcoholic Fatty Liver Disease Using FibroScan(®) CAP Values among the Taiwanese Population
title_sort efficacy of anthropometric indicators in predicting non-alcoholic fatty liver disease using fibroscan(®) cap values among the taiwanese population
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526368/
https://www.ncbi.nlm.nih.gov/pubmed/37760959
http://dx.doi.org/10.3390/biomedicines11092518
work_keys_str_mv AT leemengszu theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT felipedimogevabelingon theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT yangjengfu theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT chenyiyu theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT wukuanta theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT kuohsiangju theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT lintzuchun theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT wangchaoling theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT hsiehmenghsuan theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT linchiayi theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT batsaikhanbatbold theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT hochikung theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT wumingtsang theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT daichiayen theefficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT leemengszu efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT felipedimogevabelingon efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT yangjengfu efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT chenyiyu efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT wukuanta efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT kuohsiangju efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT lintzuchun efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT wangchaoling efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT hsiehmenghsuan efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT linchiayi efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT batsaikhanbatbold efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT hochikung efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT wumingtsang efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation
AT daichiayen efficacyofanthropometricindicatorsinpredictingnonalcoholicfattyliverdiseaseusingfibroscancapvaluesamongthetaiwanesepopulation